510(k) Report

510(k) · Cleared

Recalled · Class II · 2016

Novation Splined RDD Femoral Stems

K063279510(k) SpecialCleared Nov 29, 200629-day reviewClass II21 CFR 888.3353Recalls 2

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Exactech, Inc. · LZO Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented

Cleared on Nov 29, 2006 as substantially equivalent to K042842 (Exactech, Inc., 2004) after a 29-day review. Its family tree reaches back 6 generations to 1994. It has been recalled 2 times.

Decided
Nov 29, 2006
Review
29 days
Class
Class II
Product code
LZO
Recalls
2
Predicates
1

Its longest line of descent runs back 6 generations to K931641 (1994). 18 ancestors in all, the oldest K862234 (1986). No later device cites it as a predicate yet.

Other ancestors, by year cleared 2000: 2 other ancestors1999: 3 other ancestors1996: 2 other ancestors1986: 1 other ancestor1994: 2 other ancestors1993: 2 other ancestorsK931641 · Porocoat Porous Coating · Depuy, Inc. · 1994K003800 · Aml Hip Prosthesis · DePuy Orthopaedics, Inc. · 2001K012364 · Aml Hip Prosthesis · DePuy Orthopaedics, Inc. · 2001K030236 · Acumatch P-Series Porous Press-Fit Femoral Component · Exactech, Inc. · 2003×2: 2 generations cleared close together, K041906 (2004), K042842 (2004) 19851990199520002005
  1. Root · 6 generations backK931641 Porocoat Porous CoatingDepuy, Inc. · 1994
  2. 5 generations backK003800 Aml Hip ProsthesisDePuy Orthopaedics, Inc. · 2001
  3. 4 generations backK012364 Aml Hip ProsthesisDePuy Orthopaedics, Inc. · 2001
  4. 3 generations backK030236 Acumatch P-Series Porous Press-Fit Femoral ComponentExactech, Inc. · 2003
  5. 2 generations backK041906 Exactech 12/14 Total Hip SystemExactech, Inc. · 2004 · Recalled
  6. 1 generation backK042842 Novation 12/14 Press-Fit Femoral StemExactech, Inc. · 2004
  7. This deviceK063279 Novation Splined RDD Femoral StemsExactech, Inc. · 2006
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K931641Porocoat Porous CoatingDepuy, Inc.1994—
−5K003800Aml Hip ProsthesisDePuy Orthopaedics, Inc.2001—
−4K012364Aml Hip ProsthesisDePuy Orthopaedics, Inc.2001—
−3K030236Acumatch P-Series Porous Press-Fit Femoral ComponentExactech, Inc.2003—
−2K041906Exactech 12/14 Total Hip SystemExactech, Inc.20041
−1K042842Novation 12/14 Press-Fit Femoral StemExactech, Inc.2004—
0 (this device)K063279Novation Splined RDD Femoral StemsExactech, Inc.2006—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198610
199320
199420
199620
199930
200020
FIG. 1 — Lineage of K063279, 1994–2006Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LZO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LZO device

  1. #1 K192827 Quadra-Pscore 19.3 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K042842Novation 12/14 Press-Fit Femoral Stem
Summary page 2
…Information on devices to which substantial equivalence is claimed: 510(k) Trade or Proprietary or Model Name Manufacturer Number #K042842 Novation 12/14 Press-Fit Femoral Stems Exactech, Inc. INDICATIONS FOR USE: All Exactech Hip Syst…
Exactech, Inc.2004—

Also cleared against K042842: 5 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
May 26, 2016Class IIZ-2127-2016Under Investigation by firmLabeled with the incorrect Global Trade Item Number (GTIN). The GTIN on the label identifies the devices as another.
May 26, 2016Class IIZ-2128-2016Under Investigation by firmLabeled with the incorrect Global Trade Item Number (GTIN). The GTIN on the label identifies the devices as another.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 12 years and passes through 3 companies; a new generation was cleared every 1.6 years on median.
  • 3 of the 18 ancestors have a recall of any class.
  • 5 other devices also cite its predicate K042842.

How does its category compare?

All LZO devices

LZO Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LZO

14in 2025

2007: 92008: 112009: 72010: 152011: 132012: 142013: 262014: 132015: 122016: 102017: 162018: 182019: 282020: 182021: 122022: 112023: 102024: 112025: 142026 (partial year): 9
2007high 28 (2019) · low 7 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LZO

119in 2025

2007: 87 days median2008: 63 days median2009: 83 days median2010: 78 days median2011: 87 days median2012: 98 days median2013: 100 days median2014: 85 days median2015: 115 days median2016: 177 days median2017: 257 days median2018: 163 days median2019: 109 days median2020: 112 days median2021: 170 days median2022: 279 days median2023: 122 days median2024: 111 days median2025: 119 days median2026 (partial year): 102 days median
2007high 279 (2022) · low 63 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LZO

1in 2025

2007: 22008: 132009: 422011: 102012: 142014: 12015: 12016: 92017: 52018: 22019: 42020: 32022: 42023: 22024: 12025: 1
2007high 42 (2009) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LZO

3,244in 2025

2007: 1382008: 1252009: 1892010: 3942011: 5442012: 9632013: 1,3702014: 1,4772015: 1,3482016: 1,7282017: 2,1652018: 3,1332019: 3,0662020: 1,9632021: 2,1992022: 1,9852023: 2,0662024: 2,5862025: 3,244
2007high 3,244 (2025) · low 125 (2008)2025

MAUDE reports naming product code LZO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20079872138
2008116313125
200978342189
201015780394
2011138710544
2012149814963
20132610001,370
2014138511,477
20151211511,348
20161017791,728
20171625752,165
20181816323,133
20192810943,066
20201811231,963
20211217002,199
20221127941,985
20231012222,066
20241111112,586
20251411913,244
202691020—

What is it indicated for?

All Exactech Hip Systems are indicated for use in skeletally mature individuals undergoing primary surgery for hip replacement due to osteoarthritis, rheumatoid arthritis, osteonecrosis, post-traumatic degenerative problems of the hip, and for treatment of proximal femoral fractures where prosthetic replacement is determined by the surgeon as the preferred treatment. Components of Exactech Hip Systems are also potentially indicated for ankylosing…

Read the full statement (139 words)

All Exactech Hip Systems are indicated for use in skeletally mature individuals undergoing primary surgery for hip replacement due to osteoarthritis, rheumatoid arthritis, osteonecrosis, post-traumatic degenerative problems of the hip, and for treatment of proximal femoral fractures where prosthetic replacement is determined by the surgeon as the preferred treatment. Components of Exactech Hip Systems are also potentially indicated for ankylosing spondylitis, congenital hip dysplasia, revision of failed previous reconstructions where sufficient bone stock is present, and to restore mobility resulting from previous fusion.

Cemented femoral stems and cemented acetabular cups are intended for cemented fixation only.

Press-fit femoral stems and acetabular cups are intended for press-fit fixation.

Press-fit components without hydroxyapatite (HA) coating may also be used with bone cement at the discretion of the surgeon.

Femoral heads and endoprostheses are intended for use in cemented and press-fit applications.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K063279: Novation Splined RDD Femoral Stems.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K063279

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026